Literature DB >> 27619257

Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do?

Ioulia Chatzistamou1, Hippokratis Kiaris2.   

Abstract

The continuous supplementation of mice with supraphysiological doses of estrogen 
for the growth of estrogen receptor-positive breast cancers has been linked to toxicity in the host and perturbation of cancer cells' function that can misguide preclinical studies. Thus, alternative experimental models with circulating levels of estrogens higher than those of mice may represent more suitable hosts to model estrogen receptor-positive breast cancers.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  breast cancer; cancer model; estrogen receptor; estrogen supplementation

Mesh：

Substances：

Year:  2016        PMID： 27619257      PMCID： PMC5063077          DOI： 10.1530/ERC-16-0397

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


  13 in total

1.  Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.

Authors:  Daniel J Haisenleder; Aleisha H Schoenfelder; Elizabeth S Marcinko; Lisa M Geddis; John C Marshall
Journal:  Endocrinology       Date:  2011-09-20       Impact factor: 4.736

2.  Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats.

Authors:  Robert K Dearth; Jill K Hiney; Vinod K Srivastava; Alina M Hamilton; William L Dees
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-20

3.  Generation of Esr1-knockout rats using zinc finger nuclease-mediated genome editing.

Authors:  M A Karim Rumi; Pramod Dhakal; Kaiyu Kubota; Damayanti Chakraborty; Tianhua Lei; Melissa A Larson; Michael W Wolfe; Katherine F Roby; Jay L Vivian; Michael J Soares
Journal:  Endocrinology       Date:  2014-02-07       Impact factor: 4.736

4.  Past, present, and future challenges in breast cancer treatment.

Authors:  George W Sledge; Eleftherios P Mamounas; Gabriel N Hortobagyi; Harold J Burstein; Pamela J Goodwin; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

5.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.

Authors:  H Offner; K Adlard; A Zamora; A A Vandenbark
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Steroid hormones content and proteomic analysis of canine follicular fluid during the preovulatory period.

Authors:  Somayyeh Fahiminiya; Karine Reynaud; Valérie Labas; Séverine Batard; Sylvie Chastant-Maillard; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2010-11-01       Impact factor: 5.211

7.  Substantial discrepancies in 17beta-oestradiol concentrations obtained with three different commercial direct radioimmunoassay kits in rat sera.

Authors:  Jakob O Ström; Annette Theodorsson; Elvar Theodorsson
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

8.  Evaluation of cyclosporine-treated mice as hosts for growing and testing the chemosensitivity of first-transplant-generation human tumor xenografts implanted under the kidney capsule.

Authors:  J A Bennett; V A Pilon; D R Briggs; M F McKneally
Journal:  J Natl Cancer Inst       Date:  1985-11       Impact factor: 13.506

9.  Transplantation of human or rodent tumors into cyclosporine-treated mice: a feasible model for studies of tumor biology and chemotherapy.

Authors:  H J Fingert; A Treiman; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 10.  Interpreting plasma estrogen levels in breast cancer: caution needed.

Authors:  Elizabeth J Folkerd; Per E Lønning; Mitch Dowsett
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544
View more
  3 in total

1.  An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.

Authors:  Sandra D Scherer; Alessandra I Riggio; Fadi Haroun; Yoko S DeRose; H Atakan Ekiz; Maihi Fujita; Jennifer Toner; Ling Zhao; Zheqi Li; Steffi Oesterreich; Ahmed A Samatar; Alana L Welm
Journal:  Breast Cancer Res       Date:  2021-10-30       Impact factor: 6.466

2.  Growth of human breast cancers in Peromyscus.

Authors:  Vimala Kaza; Elena Farmaki; Amanda Havighorst; Janet Crossland; Ioulia Chatzistamou; Hippokratis Kiaris
Journal:  Dis Model Mech       Date:  2018-01-17       Impact factor: 5.758

Review 3.  Management and potentialities of primary cancer cultures in preclinical and translational studies.

Authors:  Giacomo Miserocchi; Laura Mercatali; Chiara Liverani; Alessandro De Vita; Chiara Spadazzi; Federica Pieri; Alberto Bongiovanni; Federica Recine; Dino Amadori; Toni Ibrahim
Journal:  J Transl Med       Date:  2017-11-07       Impact factor: 5.531
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.